Literature DB >> 29177162

Surgical Treatment of Small Intestinal Neuroendocrine Tumors G1/G2.

Andreas Selberherr1, Martin B Niederle2, Bruno Niederle3.   

Abstract

Although the majority of neuroendocrine tumors of the small intestine (siNETs) classified as low-grade G1 or G2 show slow local growth, they are frequently diagnosed at an advanced stage of metastatic disease. The surgical treatment is curative in stages I-III or palliative in stage IV in an attempt to avoid local complications of bowel obstruction and ischemia of the small bowel by unremoved lymph node metastases. Individualized surgical procedures performed by experienced surgeons considering tumor multifocality and the primary extent of lymph node metastases along the mesenteric vessels are recommended to remove as much tumor volume as possible, while avoiding major complications intraoperatively and small bowel syndrome postoperatively.

Entities:  

Keywords:  Ileum; Jejunum; Neuroendocrine neoplasia; Neuroendocrine tumor; Small intestine

Year:  2017        PMID: 29177162      PMCID: PMC5697499          DOI: 10.1159/000477786

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  15 in total

1.  ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum.

Authors:  B Niederle; U-F Pape; F Costa; D Gross; F Kelestimur; U Knigge; K Öberg; M Pavel; A Perren; C Toumpanakis; J O'Connor; D O'Toole; E Krenning; N Reed; R Kianmanesh
Journal:  Neuroendocrinology       Date:  2016-01-12       Impact factor: 4.914

Review 2.  Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.

Authors:  G Capurso; M Rinzivillo; R Bettini; L Boninsegna; G Delle Fave; M Falconi
Journal:  Br J Surg       Date:  2012-09-13       Impact factor: 6.939

3.  Clinical signs of fibrosis in small intestinal neuroendocrine tumours.

Authors:  K Daskalakis; A Karakatsanis; P Stålberg; O Norlén; P Hellman
Journal:  Br J Surg       Date:  2016-11-10       Impact factor: 6.939

Review 4.  Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors.

Authors:  Louis de Mestier; Sophie Lardière-Deguelte; Hedia Brixi; Dermot O'Toole; Philippe Ruszniewski; Guillaume Cadiot; Reza Kianmanesh
Journal:  Neuroendocrinology       Date:  2015-01-09       Impact factor: 4.914

5.  Method for dissection of mesenteric metastases in mid-gut carcinoid tumors.

Authors:  U Ohrvall; B Eriksson; C Juhlin; S Karacagil; J Rastad; P Hellman; G Akerström
Journal:  World J Surg       Date:  2000-11       Impact factor: 3.352

6.  Prophylactic cholecystectomy in midgut carcinoid patients.

Authors:  Olov Norlén; Ola Hessman; Peter Stålberg; Göran Akerström; Per Hellman
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

7.  Desmoplasia: a response or a niche?

Authors:  Yves A DeClerck
Journal:  Cancer Discov       Date:  2012-09       Impact factor: 39.397

8.  Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

Authors:  Martyn E Caplin; Marianne Pavel; Jarosław B Ćwikła; Alexandria T Phan; Markus Raderer; Eva Sedláčková; Guillaume Cadiot; Edward M Wolin; Jaume Capdevila; Lucy Wall; Guido Rindi; Alison Langley; Séverine Martinez; Joëlle Blumberg; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2014-07-17       Impact factor: 91.245

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

10.  Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study.

Authors:  Martyn E Caplin; Marianne Pavel; Jarosław B Ćwikła; Alexandria T Phan; Markus Raderer; Eva Sedláčková; Guillaume Cadiot; Edward M Wolin; Jaume Capdevila; Lucy Wall; Guido Rindi; Alison Langley; Séverine Martinez; Edda Gomez-Panzani; Philippe Ruszniewski
Journal:  Endocr Relat Cancer       Date:  2016-01-07       Impact factor: 5.678

View more
  5 in total

1.  Neuroendocrine Tumors of the Gastrointestinal Tract.

Authors:  Detlef K Bartsch; Hans Scherübl
Journal:  Visc Med       Date:  2017-10-16

2.  The Number of Lymph Nodes Examined is Associated with Survival Outcomes of Neuroendocrine Tumors of the Jejunum and Ileum (siNET): Development and Validation of a Prognostic Model Based on SEER Database.

Authors:  Peng Wang; Erlin Chen; Mingjie Xie; Wei Xu; Chaoyang Ou; Zhou Zhou; Yuanjie Niu; Wei Song; Qingfeng Ni; Jianwei Zhu
Journal:  J Gastrointest Surg       Date:  2022-06-10       Impact factor: 3.267

3.  Neuroendocrine Liver Metastasis-a Specific Set of Markers to Detect Primary Tumor Sites.

Authors:  Andreas Selberherr; Oskar Koperek; Philipp Riss; Christian Scheuba; Reto Kaderli; Aurel Perren; Bruno Niederle
Journal:  Endocr Pathol       Date:  2019-03       Impact factor: 3.943

4.  Neuroendocrine liver metastasis from the small intestine: Is surgery beneficial for survival?

Authors:  Andreas Selberherr; Simon Freermann; Oskar Koperek; Martin B Niederle; Philipp Riss; Christian Scheuba; Bruno Niederle
Journal:  Orphanet J Rare Dis       Date:  2021-01-14       Impact factor: 4.123

Review 5.  Diagnosis and management of small bowel neuroendocrine tumors: A state-of-the-art.

Authors:  Jhean Gabriel Gonzáles-Yovera; Pela J Roseboom; Marcio Concepción-Zavaleta; Isamar Gutiérrez-Córdova; Esteban Plasencia-Dueñas; María Quispe-Flores; Anthony Ramos-Yataco; Carlos Alcalde-Loyola; Frederick Massucco-Revoredo; José Paz-Ibarra; Luis Concepción-Urteaga
Journal:  World J Methodol       Date:  2022-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.